Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
In this randomized, double-blind, placebo-controlled, multicentre trial, 126 patients between
July 5, 2007 and July 30, 2008 were enrolled from 10 centers. The leader units are Shanghai
Chest Hospital Affiliated to Shanghai Jiao-Tong University and Shanghai Changzheng Hospital.
All eligible patients received 1 cycle (21 days) of TC chemotherapy. After chemotherapy,
patients evaluated as SD (Stable Disease) or above were randomized to receive endostar plus
TC or TC alone for 3 cycles, 21 days as one cycle.